News
![](/images/news/Actualite_PHOSISTOS.jpg)
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
![](/images/news/Actualite_PAGETEX.jpg)
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
![](/images/news/News_PrixTransAzais.jpeg)
On November 8th and 9th, 2018, the Cancéropole Nord-Ouest organized the second edition of the "Translationnelles" days: "Ovarian cancer - from biology to clinic" in Caen, France.
![](/images/news/image-news-nature-2018.jpg)
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
![](/images/news/news-fondations.jpg)
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
![](/images/news/Actualite_INDYGO-fin-inclusion-2018.jpg)
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
![](/images/news/LSM50.png)
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
![](/images/news/Actualite_EAMBES.png)
Prof. Serge Mordon promoted Fellow of the European Alliance for Medical and Biological Engineering & Science
![](/images/news/Actualite_EuroPDT.jpg)
OncoThAI will attend the 17th Congress of the European Society for Photodynamic Therapy in Nice, France On March 16th and 17th 2018.